Gary Glick raises another $101M for immuno-oncology startup Odyssey Therapeutics


It's the third nine-figure round the Boston-based startup has raised in as many years.

Previous HealthStream expands services to nursing schools, students to increase revenue
Next Temple Health opens community health hub inside a North Philadelphia Shop Rite